Skip to content
Sign in
Artwork for Dr. John Campbell
EducationHealth & FitnessMedicine

Dr. John Campbell

Campbellteaching

Hello Everyone, My name is John Campbell and I am a retired Nurse Teacher and former clinical nurse based in England. I also do some teaching in Asia and Africa when time permits. These videos are to help students to learn the background to all forms of health care. My PhD focused on the development of open learning resources for nurses nationally and internationally. LinkedIn profile, https://www.linkedin.com/in/dr-john-campbell-5256223b/ Twitter, https://twitter.com/Johnincarlisle Disclaimer; These media including videos, book, e book, articles, podcasts are not peer-reviewed. They should never replace individual clinical judgement from your own health care provider. No media-based material on this channel is suitable for using as professional medical advice. All comments are also for educational purposed only and must never replace advice from your own health care provider

Play
Open in
  • 773 episodes
  • daily
  • Avg 24 min
  • English

Episodes 773

NewestOldestLongest
All20Unplayed20In progress0Played0
Counted on this page — what you have heard stays on this device, so it is not something the list can be paged by.
  • October 6 · 18 min

    US, Mass disabling event

    7.5% of US adults are currently reporting Long Covid, is the a mass disabling event? Uploaded 17-09-22 Nearly One in Five American Adults Who Have Had COVID-19 Still Have “Long COVID” https://www.cdc.gov/nchs/pressroom/nchs_press_releases/2022/20220622.htm More than 40% of adults in the United States reported having COVID-19 in the past Of this 40% 19% are currently still having symptoms of “long COVID” (20 minutes, online survey) https://www.cdc.gov/nchs/covid19/pulse/long-covid.htm For all U.S. adults, the new data show Overall, 1 in 13 adults in the U.S. (7.5%) have “long COVID” symptoms, (symptoms lasting three or more months first infection) UK comparison, is 3.1% Male v female Women, 9.4% Men, 5.5% UK comparison, also more common in women Older v younger Nearly three times more common in 50-59 than 80 and older. UK comparison, also more common in 35 to 69 years Ethnicity (adult data) Nearly 9% of Hispanic adults currently have long COVID Non-Hispanic White (7.5%) Black (6.8%) Asian adults (3.7%) Sexual orientation Bisexual adults, 12% have current long COVID symptoms Transgender adults, 15% Differences between States Highest prevalence Kentucky, 12.7% Alabama, 12.1% Tennessee, 11.6% South Dakota, 11.6% Highest prevalence Hawaii, 4.5% Maryland, 4.7% Virginia, 5.1% The Great Resignation Event https://www.bls.gov/opub/mlr/2022/article/the-great-resignation-in-perspective.htm Over the last year, rate of job quitting, highest since records began in 2000 https://fred.stlouisfed.org/series/LMJVTTUVUSQ647S Available jobs, 11.3 million Is this a Mass Disabling Event? Caused by the ‘The Great Resignation Event’ White collar workers Teachers Health care workers Restaurant and food workers Comparison with UK, ONS data https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19/latestinsights As of 1st September, 2022 (from 21 July, 2022) People experiencing self-reported long COVID 2.0 million (3.1% of the population) Of this 2 million Symptoms for at least 12 weeks, 83% Symptoms for at least 1 year, 45% Symptoms for at least 2 years, 22% The most common long COVID symptoms Fatigue, 62% Shortness of breath, 37% Difficulty concentrating, 33% Muscle ache, 31% Symptoms adversely affected the day-to-day activities In 73% of those with self-reported long COVID  More common in Aged 35 to 69 years Females Living in more deprived areas Workers in social care Another activity-limiting health condition or disability Less common in those looking for work Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 6 · 23 min

    Worst cold ever

    UK, Worst cold ever, Government data W/E 19th September Download my two comprehensive but free educational text books, with hundreds of illustrations, and / or make a donation to the campbellteaching project using this link: http://159.69.48.3 Ive always got various health related projects on the go Uploaded 24-09-21 https://coronavirus.data.gov.uk https://www.theguardian.com/society/2021/sep/24/return-of-the-common-cold-infections-surge-in-uk-as-autumn-arrives https://www.gov.uk/government/publications/syndromic-surveillance-weekly-summaries-for-2021 111 calls for respiratory-type indicators increased nationally Particularly, 1-14 years Also, potential covid-19 assessments, 5-14 year olds Common colds are caused by: 100 different rhinoviruses Respiratory syncytial virus Adenoviruses Four types of coronavirus Influenza Parainfluenza Dr Gary Howsam, vice-chair of the Royal College of GPs we are starting to see a major resurgence of illnesses like common colds, flu and stomach bugs, alongside the Covid-19 virus in the community Symptoms of Covid-19 can often be similar to symptoms of other illnesses such as the common cold. So it’s important that if a patient does experience symptoms of Covid-19, such as a high temperature, a new continuous cough, or a loss or change to sense of smell or taste that they get a PCR test immediately, and on receiving a positive result, self-isolate for the required period of time Dr Yvonne Doyle, medical director at Public Health England Hand washing, ventilation and mask wearing aren’t only important for Covid-19, they keep other bugs at bay too Do I have COVID or a cold? https://covid.joinzoe.com/post/do-i-have-covid-or-a-cold-how-to-tell-the-difference Vaccinated or not Anosmia is one of the most important predictors of testing positive for COVID-19 rather than a regular cold If fully vaccinated (as of 21st September) Runny nose Headache Sneezing Sore throat Anamosa If unvaccinated Headache Runny nose Sore throat Fever Persistent cough Anosmia Other symptoms https://covid.joinzoe.com/post/the-20-symptoms-of-covid-19-to-watch-out-for Chills or shivers Loss or change of taste Fatigue Delirium Skin rash Changes in mouth or tongue Red and sore fingers or toes Shortness of breath Chest pain Muscle pain Hoarse voice Diarrhoea Anorexia Abdominal pains If you feel newly unwell, especially if you’re suffering from any of the common covid symptoms, stay home and get a COVID test, even if you’ve been vaccinated. Lateral flow test https://www.gov.uk/government/news/new-analysis-of-lateral-flow-tests-shows-specificity-of-at-least-999 99.9% specificity May be 99.97% Low false positive rate A negative result from a lateral flow test is not totally reliable High false negative rate https://pharmaceutical-journal.com/article/feature/how-reliable-are-lateral-flow-covid-19-tests 72% picked up in those with symptoms 58% picked up in those without symptoms So if your symptoms persist it’s best to get a PCR test Learn more about your ad choices. Visit megaphone.fm/adchoices Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 6 · 28 min

    FenBen in Stage 4 tumors

    Fenbendazole and cancer https://karger.com/cro/article-pdf/18/1/856/4381509/000546362.pdf Fenbendazole, inexpensive, widely accessible antiparasitic drug used in veterinary medicine Patent expired in the early 1990s, making FBZ available as a generic drug Case 1 An 83-year-old female October 2021 Stage 4 breast cancer Initially diagnosed in 2009 Treated 2009, bilateral mastectomy Recurrence was diagnosed in 2021. Liver biopsy, confirmed metastatic breast Ascitic fluid confirmed metastatic breast carcinoma. Magnetic resonance imaging of the spine, October 2021 metastatic breast cancer, T10, T12, L1, L2, L3, L4, L5, S1, S2, and the iliac bones. A PET/CT scan on December 29, 2021, showed six hypermetabolic lung lesions Largest was 2.8 × 1.5 cm Hypermetabolic liver lesions, 2.9 × 1.7 cm Hypermetabolic bone lesions, notably a 5.0 × 2.9 cm lytic lesion in L4, extending into the spinal canal, etc The patient declined further conventional chemotherapy or radiation therapy and was placed under hospice care. November 22, 2021 Self-administering FBZ daily at a dose of 222 mg. In December 2021, she received fulvestrant injection, (an estrogen receptor blocker) intended to inhibit cancer growth January 2022 Targeted radiation for two painful spinal metastases. These tumors disappeared rapidly, relieving her pain within a few days. Continued taking 222 mg/day of FBZ for 8 months. During this time, her liver enzymes normalized CA 27.29 tumor marker dropped from 316 (November 2021) to 36.6 (July 2022) April 20, 2022, PET scan confirmed the absence of any abnormal metabolic activity indicative of cancer. June 2022 Patient was confirmed to have no evidence of active disease. All treatments were discontinued, and she was considered to be in complete remission. Follow-up monitoring was scheduled every 3–6 months. Throughout her FBZ treatment, she continued her regular supplementation of vitamin D (5,000 IU) and a multivitamin. Subsequent PET scans showed no abnormal metabolic activity. The FBZ treatment period revealed no adverse effects at this dosage. The patient remains recurrence-free and continues to take FBZ daily nearly 3 years after being declared to be in remission. Joe Tipp’s Protocol https://www.fenbendazole.org/fenbendazole-information/fenbendazole-dosage-guide/ Case 2, Prostate cancer, 75 year old man Bone scans and CT scans, metastases in the spine, pelvic bones, and right humeral head Conventional treatments Complementary treatments The use of FBZ coincided with continued regression of metastatic lesions and sustained undetectable PSA levels After 26 months of sustained regression and no new progression, the patient remains in near-complete response and continues FBZ with conventional therapy Case 3, 63-year-old man Hip growth, melanoma. PET-CT showed multiple hypermetabolic foci – peritoneal and retroperitoneal nodules, focal uptake in the stomach and small bowel, lesions in the right gluteus medius, quadratus femoris, and L5 vertebra. Conventional and complementary treatments The patient remains melanoma recurrence-free over 11 months after being declared to be in remission. Case Presentations All three patients, no reported adverse effects Conclusion FBZ demonstrates potential as a novel promising therapeutic option for repurposing in oncology. Its ability to contribute to tumor regression and achieve disease remission warrants further clinical research to establish its efficacy and optimize its use. Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 6 · 7 min

    Child excess deaths, 8%

    Direct link to parliament TV, https://parliamentlive.tv/Event/Index/5e1f14d2-72b3-488f-a53c-fc94fee92dac Link to Hansard full transcript, https://hansard.parliament.uk/Commons/2024-01-16/debates/152B485D-812D-43CC-9D25-C2B651564810/ExcessDeathTrends?highlight=westminster%20hall#contribution-46059AFE-9A03-472B-9364-0BF972E2E7D8 Full speech from Dr. Johnson This is a very important debate and I will try to make my speech as short as possible. I congratulate the hon. Member for North West Leicestershire on raising this issue and on his determination to highlight the challenges that we are facing. On the one hand, we might have expected that the pandemic would shorten the lives of a number of our more frail citizens and thus have expected a fall in deaths post-pandemic, and we saw that. The ONS reported roughly 608,000 deaths in England and Wales in 2020, 586,000 in 2021, and 577,000 in 2022—that was higher than 2019 when there were about 531,000 deaths, so that does warrant further inspection. We expect a fluctuation year on year, and we also expect Toggle showing location of Column 221WH the total number of deaths to increase year on year as the population increases and ages. We therefore look at the five-year average, and currently we are using 2017, 2018, 2019, 2021 and 2022 because of the outliers in 2020. Even then, it is unlikely that we will be exactly at the average, and we would expect some years to be higher or lower. The ONS monthly mortality analysis shows that, in 2022, there were 32,000 more deaths than the five-year average, and in January to July 2023, there were 21,809 more. That equates to an annualised figure of around 37,000, but the figures appear to stop in July 2023. Would the Minister advise as to why the data series has been discontinued? It would be helpful if it were not. However, those are raw numbers and we must be cautious because, as the population ages and increases, so will the number of deaths. The ONS therefore uses the age-standard mortality rate, which has fluctuated month on month but is actually down for both 2022 and 2023 when compared with the five-year average. Overall, when adjusted for age and population size, the number of deaths is not excessive, given what we would expect. We need to look further at the trends on age and the causes of death to see a fuller picture. Others will no doubt speak of rising cardiovascular disease in men, the late presentation of cancers or the rise in liver disease, but as a consultant paediatrician, I would like to focus on children. The National Child Mortality Database collates data on children’s deaths from nought to 18. Its latest bulletin from March 2023 shows that there were sadly 3,743 deaths to the end of that month, which is an increase of 8% on the previous year. Would the Minister comment on what investigation she is doing into the cause of that increased mortality and what is being done to prevent further deaths? The purpose of the child death overview panel is to investigate those deaths, but the average investigation is taking 392 days, with less than half completed in 12 months and a significant fall in the number being completed in 12 months. What is the Minister doing to improve that process? One particularly distressing feature of child death data is that suicide or deliberate self-harm was a primary cause of death of children between 10 and 17 years, and looking at the data, it is getting much worse with children between 10 and 14. I understand that the Government are aware of those figures and are investing in mental health for children and improving online safety. I would be grateful if the Minister elaborated further on the steps they are taking to support children and prevent further tragedies. Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 6 · 25 min

    BA.5 causes more severe disease

    UK infections continue upwards https://health-study.joinzoe.com/data Reinfections now common https://www.independent.co.uk/news/health/covid-omicron-reinfection-symptoms-uk-cases-b2115027.html https://www.science.org/doi/10.1126/science.abq1841 Generally, infections tend to milder the second or third time round Danny Altmann, professor of immunology, Imperial College London Omicron is poorly immunogenic, which means that catching it offers little extra protection against catching it again Prof Tim Spector There are definitely a lot of people who got Covid at the start of the year who are getting it again, including some with BA.4/5 who had BA.1/2 just four months ago rare to be reinfected with within three months BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection https://www.nature.com/articles/s41586-022-04980-y?utm_medium=affiliate&utm_source=commission_junction&utm_campaign=CONR_PF018_ECOM_GL_PHSS_ALWYS_PRODUCT&utm_content=textlink&utm_term=PID100062364&CJEVENT=e070b984fbde11ec819046bd0a180514 New sub-variants notably evade the neutralising antibodies elicited by SARS-CoV-2 infection and vaccination Vaccine boosters based on the BA.1 virus (e.g. those developed by Pfizer/BioNTech and Moderna) may not achieve broad-spectrum protection against new Omicron variants Dr. Onyema Ogbuagu, Yale School of Medicine, Connecticut My personal bias is that while there may be some advantage to having an Omicron-specific vaccine, I think it will be of marginal benefit over staying current with the existing vaccines and boosters Despite immune evasion, the expectation can be that vaccines will still protect against serious disease What we’ve learned clinically is that it’s most important to stay up-to-date with vaccines to maintain high levels of COVID-19 antibodies circulating in the blood Kei Sato, University of Tokyo New sub-variants may have evolved to refavour infection of lung cells Risk is potentially greater than that of original BA.2 Dr Stephen Griffin, University of Leeds It looks as though these things are switching back to the more dangerous form of infection, so going lower down in the lung Neutralization Escape by SARS-CoV-2 Omicron Subvariants BA.2.12.1, BA.4, and BA.5 https://www.nejm.org/doi/full/10.1056/NEJMc2206576 Subvariants BA.1 and BA.2, substantial escape from neutralizing antibodies Subvariants BA.4 and BA.5 have identical sequences of spike protein Comparison of neutralizing antibody titer WA1/2020 isolate with BA.1, BA.2, BA.2.12.1, and BA.4 or BA.5 Isolate USA-WA1/2020 from an oropharyngeal swab, returned from China, who and developed clinical disease, January 2020 in Washington, USA In 27 participants, all vaccinated and boosted with Pfizer, And 27 participants who had been infected with the BA.1 or BA.2 median 29 days earlier (range, 2 to 113 days) In the vaccine cohort Participants were excluded, if they had a history of SARS-CoV-2 infection, or a positive result on nucleocapsid serologic analysis, or if they had received another covid vaccine, or an immunosuppressive medication Six months after the initial two BNT162b2 immunizations Neutralizing antibody titer against WA1/2020 = 124 Neutralizing antibody titer against omicron subvarients = 20 Two weeks after administration of the booster dose Neutralizing antibody titer against WA1/2020 = 5,783 Neutralizing antibody titer against BA.1 = 900 BA.2 = 892 BA.2.12.1 = 410 BA.4 or BA.5 = 275 (21 times lower than 5,783) What about natural immunity Among the participants who had been infected with BA.1 or BA.2, 26 had been vaccinated Median neutralizing antibody titer WA1/2020 isolate = 11,050 BA.1 = 1,740 BA.2 = 1,910 BA.2.12.1 = 1,150 BA.4 or BA.5 = 590 (18.7 times less than 11,050) These data show that the BA.2.12.1, BA.4, and BA.5 subvariants substantially escape neutralizin Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 6 · 15 min

    CDC, natural immunity left out

    This covid winter should be better than last Dr. Anthony S. Fauci, President Biden’s chief medical adviser https://www.nytimes.com/2022/11/22/us/politics/fauci-covid-winter-surge.html https://www.washingtonpost.com/health/2022/11/22/covid-bivalent-booster/?utm_campaign=wp_to_your_health&utm_medium=email&utm_source=newsletter&wpisrc=nl_tyh Combination of infections and vaccinations, enough community protection that we’re not going to see a repeat of what we saw last year at this time Re bivalent effectiveness It is clear now, despite an initial bit of confusion United States Nearly $5 billion to buy 171 million bivalent boosters (Pfizer BioNTech, Moderna) Hobson’s choice Dr. Ashish K. Jha, White House’s Covid-19 response coordinator Still heavily promoting vaccination Nothing I have seen in the subvariants makes me believe that we can’t manage our way through it effectively, especially if people step up and get their vaccine So far, 35 million people, (11% of over 5s) one bivalent shot https://www.cdc.gov/mmwr/volumes/71/wr/mm7148e1.htm?s_cid=mm7148e1_w Effectiveness of Bivalent mRNA Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to Testing Program, United States, September–November 2022 This is the clinical trial, previous work had only been based on antibodies Benefits are mentioned, adverse reactions are not Any adverse reactions not reported v-safe https://www.cdc.gov/mmwr/volumes/71/wr/mm7144a3.htm?s_cid=mm7144a3_w Systemic symptoms Fatigue (30.0%–53.1%) Headache (19.7%–42.8%) Myalgia (20.3%–41.3%) Fever (10.2%–26.3%) Reported inability to complete normal daily activities 10.6% among aged over 65 years 19.8% among aged 18–49 years Bivalent boosters provided significant additional protection against symptomatic SARS-CoV-2 infection Relative vaccine effectiveness (rVE) of a bivalent booster dose, compared with that of more than 2 monovalent vaccine doses, 30% and 56% aged 18–49 with relative benefits increasing with time since receipt of the most recent monovalent vaccine dose. Staying up to date with COVID-19 vaccination, including getting a bivalent booster dose when eligible, is critical to maximizing protection against COVID-19 350,000 tests at almost 10,000 retail pharmacies between Sept. 14 and Nov. 11 Relative risk given Absolute risk not given What about protection from severe disease? Paul Offit, director of the vaccine education center, professor of pediatrics, Children’s Hospital of Philadelphia The only reasonable goal is to prevent serious illness, We are still waiting for one shred of evidence that this bivalent vaccine or any bivalent is better than what we had Virus continues to evolve This should be a cautionary tale for what happens when you try to chase these variants Celine Gounder, infectious-disease specialist, Kaiser Family Foundation It doesn’t show the bivalents are better than the original boosters (but still advocated the bivalent shot) Pei-Yong Shi, virologist, University of Texas Medical Branch difficult to measure how well the updated boosters were working because so many people now had some immunity from earlier infections, including people who were never vaccinated or boosted. John P. Moore, virologist, Weill Cornell Medicine Are the boosters working better than the original shots? Personally, I doubt there would have been much, if any, difference, but we may never know Dr. Roby Bhattacharyya, infectious disease physician, Massachusetts General Hospital This winter should be better than last we’re a more immune population China https://www.reuters.com/world/china/chinas-daily-covid-cases-hit-record-high-2022-11-24/?utm_source=Sailthru&utm_medium=newsletter&utm_campaign=daily-briefing&utm_term=11-24-2022 https://www.telegraph.co.uk/world-news/2022/11/24/iphone-factory-staff-offered-1400-leave-i Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 6 · 15 min

    Pfizer, process 2

    Two different manufacturing processes. Pfizer covid vaccines for the clinical trials were mostly produced using manufacturing ‘process 1’ whereas the vaccines used for population vaccination were produced using a different ‘process 2’ Interview with Josh Guetzkow PhD Here is the BMJ link: https://www.bmj.com/content/378/bmj.o1731/rr-2 Josh's handle on X.com is @joshg99 and here is a link to a thread I did on P1 vs. P2: https://x.com/joshg99/status/1658421192326365185 Here is a link to my blog: https://researchrebel.substack.com/ Here are links to my posts on the Pfizer clinical trial https://researchrebel.substack.com/p/comirnaty-or-comirnaughty https://researchrebel.substack.com/p/how-long-did-the-pfizer-covid-vaccine https://researchrebel.substack.com/p/the-pfizer-vaccine-trial-was-not https://www.bmj.com/content/378/bmj.o1731/rr-2 https://www.nejm.org/doi/suppl/10.1056/NEJMoa2034577/suppl_file/nejmoa2034577_protocol.pdf https://twitter.com/joshg99/status/1658421192326365185 https://phmpt.org/wp-content/uploads/2023/04/125742_S1_M5_5351_c4591001-interim-mth6-report-body.pdf Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 6 · 24 min

    Let it rip

    , seems to be what they are saying. Dr. Ashish K. Jha, White House, Covid-19 coordinator https://www.cdc.gov/coronavirus/2019-ncov/index.html https://www.nytimes.com/live/2022/04/27/world/covid-19-mandates-vaccine-cases The new White House Covid czar says avoiding all virus infections isn’t the goal of U.S. pandemic policy. Relatively low number of new deaths, but still too high Hospitalizations, lowest point in the pandemic Rising number of cases, a promising inflection With such a contagious virus spreading, hard to ensure that no one gets Covid in America That’s not even a policy goal The goal of our policy should be: obviously minimize infections whenever possible, but to make sure people don’t get seriously ill we are going to see cases go up and go down during this pandemic as we head into the weeks, months and years ahead The more important reflections of progress, health care system strain, whether people are hospitalized with and dying from Covid-19 Paxlovid, push to reach the vulnerable Doctors are too hesitant to prescribe the drug https://www.fda.gov/media/155051/download There are some people in this country who sometimes think that we can take a domestic-only approach to a global pandemic That’s not a thing. You can’t do that Increased contagion https://covid.cdc.gov/covid-data-tracker/#variant-proportions BA.2 68.1% BA.2.12.1 28.7% Dr. Janet Woodcock, FDA It’s hard to process what’s actually happening right now, which is, most people are going to get Covid What we need to do is make sure the hospitals can still function, transportation, other essential services are not disrupted while this happens England, 10 January and 3 February 2022 New antibody saliva test https://www.lshtm.ac.uk/newsevents/news/2022/nearly-all-secondary-school-pupils-estimated-have-antibodies-against-covid-19 97% of secondary school pupils tested positive 46% vaccinated and tested positive for antibodies 51% unvaccinated and tested positive for antibodies China https://www.theguardian.com/world/2022/apr/30/beijing-bans-restaurant-dining-as-holiday-begins-in-zero-covid-clampdown https://www.youtube.com/watch?v=p5J1jYxYPJY Beijing Cases, + 54 ban dining-in negative Covid tests to visit public spaces Labour Day holiday. Prepared 4,000 temporary hospital beds Shanghai Cases, + 10,700 New cases, among quarantined or restricted groups Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 6 · 29 min

    Monkeypox, some global spread

    Cases around the world, therefore sped for past few weeks, Severe cases occur more commonly among children Monkeypox Key facts https://www.who.int/news-room/fact-sheets/detail/monkeypox https://www.telegraph.co.uk/news/2022/05/20/monkeypox-outbreak-doubles-health-authorities-set-announce-11/ Transmission Contact with an infected animal or human Respiratory droplets Lesions Skin contact Broken skin Bodily fluids Mucous membranes Contaminated materials, bed linens, clothing, towels Fomites https://www.ecdc.europa.eu/en/news-events/epidemiological-update-monkeypox-outbreak Mortality is higher among children and young adults, and immunocompromised individuals are especially at risk of severe disease. Most people recover within weeks. Most cases presented with lesions on the genitalia or peri-genital area, indicating that transmission likely occurs during close physical contact during sexual activities. US https://www.nytimes.com/article/what-is-monkeypox.html President Biden https://www.nytimes.com/2022/05/22/world/asia/monkeypox-biden-concern.html They haven’t told me the level of exposure yet, but it is something that everybody should be concerned about We’re working on it hard to figure out what we do and what vaccine may be available But it is a concern in the sense that if it were to spread it would be consequential everybody should be concerned about the rise in cases 92 confirmed cases outside Africa in the current outbreak Massachusetts, Florida, New York City https://www.cdc.gov/poxvirus/monkeypox/treatment.html Currently, there is no proven, safe treatment for monkeypox virus infection. For purposes of controlling a monkeypox outbreak in the United States, smallpox vaccine, antivirals, and vaccinia immune globulin (VIG) can be used. Spain Cases, 30, most linked to, Enrique Ruiz Escudero, cabinet minister for health Superspreader event, adult sauna, Madrid The Public Health Department will carry out an even more detailed analysis...to control contagion, cut the chains of transmission and try to mitigate the transmission of this virus as much as possible An internationally advertised gay party in Spain, being investigated as the root cause of the global monkeypox cases UK https://www.gov.uk/government/news/monkeypox-cases-confirmed-in-england-latest-updates#seven-may https://www.gov.uk/government/news/monkeypox-cases-confirmed-in-england-latest-updates Cases, 20 Contact tracing Quarantine of close contacts Belgium 3 cases inked to The Darklands Festival, Antwerp There’s reason to assume that the virus has been brought in by visitors from abroad to the festival after recent cases in other countries (Festival organisers) Darklands, ticketed event, various tribes in the gay fetish community come together to create a unique spectacle of fetish brotherhood Gay pride events Starts nowish Dr Hans Kluge, the World Health Organisation Europe As we enter the summer season in the European region, with mass gatherings, festivals and parties, I am concerned that transmission could accelerate, as the cases currently being detected are among those engaging in sexual activity, and the symptoms are unfamiliar to many Monkeypox is normally a virus that is hard to spread from one person to another, and this is the first time there has been sustained human to human transmission outside Africa. Bavarian Nordic, Bernard Hoet, (biotechnology company) an undisclosed European country, order for vaccine doses The reason why this vaccine was developed was to have a safe vaccine for stockpiling in case of outbreaks of smallpox. We are in contact with the UK authorities about the use of the vaccine. Sajid Javid Procured further doses of vaccine that are effective against monkeypox NHSE High Consequence Infection Diseases (airborne) Network / WHO Incubation, 6 to 13 days https://ww Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 6 · 25 min

    Omicron, half of regular colds

    Half of people in the UK with a common cold have a covid cold Check out Wefwafwa's channel for more about our community health work in Uganda, https://www.youtube.com/c/WefwafwaAndrew ONS, 13th December 2021 to 19th December 2021 https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/coronaviruscovid19infectionsurveypilot/24december2021 England Percentage of people testing positive for coronavirus (COVID-19), 2.83% 1,544,600 people in England had COVID-19 One in 35 people London 1 in 20 people had COVID-19 Wales, One in 45 Northern Ireland, one in 40 Scotland, one 65 people SA data https://www.worldometers.info/coronavirus/country/south-africa/ SA hospital data https://www.nicd.ac.za/diseases-a-z-index/disease-index-covid-19/surveillance-reports/daily-hospital-surveillance-datcov-report/ UK data https://coronavirus.data.gov.uk https://www.gov.uk/government/publications/covid-19-omicron-daily-overview Tim Spector https://www.youtube.com/watch?v=CIGC310hPoI&t=142s Omicron, similar cold type symptoms to delta in the first few days Omicron cases have less anosmia Fever is less common Having 5 or more symptoms less common with omicron than delta More breakthrough infections with delta, after 2 or 3 doses of vaccine Common colds less transmissible than omicron just now One in two chance common cold symptoms will test positive for covid Therefore, test for colds Avoid people who have a cold Pings are now too slow to be effective Omicron onset, 2 days rather than 5 for delta Omicron will run its course faster, all over in 4 or 5 days Infection risk after 8 days in negligible IOM, back to work when symptoms resolve and 2 lateral flow tests From 17,000 omicron cases https://covid.joinzoe.com/post/the-20-symptoms-of-covid-19-to-watch-out-for https://covid.joinzoe.com/post/everything-we-know-so-far-about-omicron https://joinzoe.com/learn/category/covid https://joinzoe.com/learn/new-omicron-variant Runny nose Headache Fatigue (either mild or severe) Sneezing Sore throat (NHS test and trace is not telling users of their Omicron status anymore) Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 6 · 20 min

    Japan proves excess deaths in vaccinated

    Japanese excess deaths after covid vaccination deaths Dr. Yasufumi Murakami, Senior Fellow, Molecular Oncology and Pharmacology https://imahealth.org/experts/yasufumi-murakami/ Research Centre for RNA Science “The more doses you get, the sooner you’re likely to die.” “…the more doses you get, the sooner you’re likely to die, within a shorter period… Among the vaccinated, death peak emerged, especially between 90- and 120-days post vaccination. “A significant peak forms at three or four months,” “It’s probably due to the vaccine’s influence, with adverse reactions occurring leading to death.” “We found that as the number of doses increases, the peak of deaths appears faster, meaning the more doses you get, the sooner you’re likely to die, within a shorter period. So, the risk increases with more doses.” “If the vaccine had no toxicity or didn’t induce death, there wouldn’t be a peak. That’s the point.” Notes from the Graph “Number of days from final vaccination to death and number of deaths.” “As the number of vaccine doses increases, the peak in deaths appears sooner.” Vigilant Fox report, Japan Releases Bombshell Vax vs. Unvax Data on 18 Million People https://www.vigilantfox.com/p/japan-releases-bombshell-vax-vs-unvax Video from: Information Disclosure Request Team, Journalist, Scientist and politician. Video released 15 June 2025 Masako Ganaha, Japanese Journalist, X link https://x.com/ganaha_masako/status/1934189173621379339 “If the government won’t do it, then the people should investigate the mass deaths of Japanese people! Database of 18 million vaccinated people revealed for the first time!” “This is a key discovery, the more doses, the more the peak shifts, indicating that the toxicity accumulates. The toxicity overlaps, and the more doses you receive, the faster people die.” Kazuhiro Haraguchi, House of Representatives https://en.wikipedia.org/wiki/Kazuhiro_Haraguchi Significant Increase in Excess Deaths after Repeated COVID-19 Vaccination in Japan https://pubmed.ncbi.nlm.nih.gov/40416011/ Although Japan recorded the world's highest rate of COVID-19 messenger ribonucleic acid (mRNA) vaccination doses per capita, (3.3 doses, 0 -8) COVID-19 cases and deaths exploded after the emergence of the Omicron variant, (despite more than 80% of the population having been fully vaccinated) followed by a significant increase in excess deaths in 2022 and 2023. Although several hypotheses have been proposed to explain these phenomena, the truth remains to be established because sufficient studies and data disclosures have not been conducted to adequately investigate the possible contribution of mRNA vaccines. The causes of the excess deaths from not only COVID-19 but also other factors after repeated mRNA vaccinations must be elucidated, given this could provide valuable information to help combat future infectious disease outbreaks. Japan, 2022 and 2023, excess deaths per million More than 1,400 (three times higher than that in the United States) COVID-19 deaths in Japan accounted for only 10% of these excess deaths Another hypothesized cause of the excess deaths is various adverse reactions to COVID-19 vaccinations. As of November 18, 2024, Japan After COVID-19 vaccination Government has provided payouts for 8, 432 injuries Payouts after 903 deaths Numbers that are still increasing, already greatly exceed the numbers of injuries and deaths, for which payments were made, after all other vaccinations in the last 47 years. Many injuries and deaths in the young population E.g. fatal case, 14-year-old girl (vaccinate to protect granny) This policy contradicts an early study (August 2021) showing vaccination did not reduce the viral load of infected individuals Adverse reactions reported Myocarditis, pericarditis, blood clotting, and autoimmune diseases linked to lipid nanoparti Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 6 · 24 min

    Sun dimming dangers

    Solar radiation modification: NOAA State of the Science factsheet https://www.climate.gov/news-features/understanding-climate/solar-radiation-modification-noaa-state-science-factsheet#:~:text=Highlights,sunlight%20away%20from%20the%20Earth. National Oceanic and Atmospheric Administration Part of the United States Department of Commerce, headquartered in Silver Spring, Maryland. SRM deployments large enough to temporarily offset climate change impacts could have substantial risks and unintended and unexpected consequences. NOAA is one of the lead federal research agencies investigating the Earth system, including the planet’s radiative balance, the global carbon cycle, and the chemistry and composition of the atmosphere. Side effects of SRM are driven by Complex chemical, radiative, and dynamical interactions, such as changes to the hydrologic cycle and clouds, or effects on ecosystems, agricultural production, https://csl.noaa.gov/assessments/ozone/2022/downloads/Chapter6_2022OzoneAssessment.pdf Impacts on the protective stratospheric ozone layer Stratospheric aerosol injection, impacts stratospheric ozone Either by direct injection or by injection of a precursor gas (such as sulfur dioxide, SO2) that would subsequently react in the stratosphere to form aerosols. SO3 + H2O – H2SO4 More likely in the presence of O3 (ozone) Proposed aerosol types include sulfate, calcium carbonate, and diamond dust. The ozone layer is a region in the Earth's stratosphere that contains a high concentration of ozone (O₃) and plays a crucial role in absorbing most of the Sun's harmful ultraviolet (UV) radiation. Marine cloud brightening, alterations to the El Niño Southern Oscillation https://www.climate.gov/enso These changes in the seasonal climate of the world's biggest ocean have a cascade of global side effects. Potential risks to human health and well-being, and to ecosystems Green House Gas induced warming and Solar Radiation Management induced cooling are different physical mechanisms; therefore, SRM would not simply undo GHG-induced warming and cannot reverse all climate changes everywhere. Some regions could experience cooler or wetter conditions, and others warmer or drier conditions, compared to a climate without SRM. In addition, ocean acidification will persist unabated if GHG emissions continue. SRM deployments large enough to temporarily offset climate change impacts could have substantial risks and unintended and unexpected consequences. Aerosols are removed from the atmosphere by natural processes on timescales of a few years in the stratosphere. Legal and societal issues SRM deployment could also add significant geopolitical risks. This uneven distribution of benefits and negative consequences introduces potentially significant justice and geopolitical concerns. Substantial knowledge gaps and uncertainties exist in many critical areas of SRM research, particularly related to the social sciences. Many of the processes most important for understanding SRM approaches—such as those that control the formation of clouds and aerosols—are among the most uncertain components of the climate system. These methods have the potential to lower surface temperatures more quickly than carbon dioxide removal (CDR) methods … while posing other risks still to be understood. Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 6 · 29 min

    Lab leak, 2020

    German spy agency 'believed Covid likely started in lab' https://www.bbc.co.uk/news/articles/cz7vypq31z7o https://www.reuters.com/business/healthcare-pharmaceuticals/german-spy-agency-concluded-covid-virus-likely-leaked-lab-papers-say-2025-03-12/ Germany's foreign intelligence service, 80-90% chance that coronavirus accidentally leaked from a Chinese lab The intelligence service BND, in 2020 Wuhan Institute of Virology had been carrying out experiments where viruses are modified to become more transmissible to humans. German primary source https://www.zeit.de/2025/11/coronavirus-ursprung-wuhan-labor-china-bnd https://www.sueddeutsche.de/projekte/artikel/gesundheit/wuhan-corona-pandemie-laborpanne-bnd-fragen-antworten-e348191/?reduced=true World Health Organization (2021) investigation Lab-leak theory "extremely unlikely" BND met in Berlin in 2020 Project Saaremaa, looking at viral origins https://www.nzz.ch/english/german-intelligence-supports-covid-19-lab-leak-theory-ld.1875253 A team of expert researchers put together Lab theory "likely" BND found indications that several violations of safety regulations had occurred at the lab. BND assessment commissioned by the office of Angela Merkel Findings were shared with the CIA in autumn of 2024. China's foreign ministry spokeswoman Mao Ning "We believe that tracing the origin of Covid-19 is a scientific issue …. "The conclusion that a laboratory leak is extremely unlikely was reached by the China-WHO joint expert team ….. "This authoritative scientific conclusion has been widely recognised by the international community…. China firmly opposes any form of political manipulation on the issue of Covid-19 origin tracing. https://www.reuters.com/world/china/china-says-wuhan-institute-was-not-involved-creating-covid-19-virus-2025-02-12/ The institute never carried out any gain-of-function research on coronaviruses NZZ (Zurich) https://www.nzz.ch/english/german-intelligence-supports-covid-19-lab-leak-theory-ld.1875253 https://www.nzz.ch/english SARS-CoV-2 virus may have been artificially engineered by modifying an existing virus, Concern, potential for another pandemic spread from a Chinese laboratory, possibly caused by a different virus. MERS risk In 2020, China was working on SARS-like coronaviruses, but also on viruses similar to those producing the Middle East respiratory syndrome, or MERS. https://cdn.fortunejournals.com/articles/discovery-of-a-novel-merbecovirus-dna.pdf MERS, fatality rate ranging from 20% to 40% The viruses responsible for MERS circulate in bats, in China for instance. In discussions of data published by Fortune Journals (Reported by NZZ) Researchers involved reached the conclusion that experimenters in Wuhan had specifically adapted the MERS virus to humans. Professor Christian Drosten (German virologist) https://www.nzz.ch/wissenschaft/corona-experte-drosten-zieht-lehren-aus-der-pandemie-die-wissenschaft-war-etwas-arrogant-ld.1842566 The MERS virus is a clear candidate for a pandemic, which is why it is being studied. But this research should not involve making it more transmissible in the laboratory. The analyses discussed by the scientists meeting with the Federal Intelligence Service reveal a significant amount of manipulation that apparently extends as far as prestigious scientific journals. Chinese state propaganda was intended to manipulate what was published in scientific journals – and it succeeded. Christian Drosten Scientific publications are subject to rigorous reviews of their quality and details. However, a deliberate, perhaps even politically motivated deception is extremely difficult to control. WHO report Viral origins outside China possible High-ranking researcher at the meetings by the Federal Intelligence Service ‘We never imagined such manipulation was possible – let alone that it would su Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 6 · 6 min

    Tribe formation

    This excellent scientific analysis of recent events continues in interview three of this series. Follow Dr. Craig on SubStack, https://drclarecraig.substack.com COVID, the untold story. So much more makes sense after this book and my first illuminating discussion with Dr. Craig. Get your copy in the UK here: https://www.amazon.co.uk/Expired-untold-Dr-Clare-Craig/dp/1739344707 For friends in the US get your copy here, https://www.amazon.com/Expired-untold-Dr-Clare-Craig/dp/1739344707 Have you ever felt the covid story did not entirely add up? Expired contains multiple eye-opening revelations about covid with compelling evidence that provides a coherent, sober and clear explanation that better fits the data we have so far. Meticulous research by pathologist Dr Clare Craig sheds light on the largely overlooked evidence of airborne virus transmission, examining twelve related beliefs on spread, lockdowns, asymptomatic infections, and masks. In addition, Expired champions the importance of Western ethical principles, damaged by pandemic actions and calls for their restoration. The covid debate has proved incredibly polarising. One side believed every intervention was saving lives, while the other emphasised the harms caused. Biased modelling based on a worst-case scenario led to fearful assumptions presented as fact. By dint of sheer repetition these ‘facts’ became unquestionable. Those scientists who dared to question were proclaimed dangerous. Welcome to Cloud-Covid-Land. Let’s bring back nuance. It’s time to return to reality." Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 6 · 18 min

    Pfizer, illegal exploitation

    £70 million in fines for pharma firms https://www.gov.uk/government/news/70-million-in-fines-for-pharma-firms-that-overcharged-nhs Overcharged NHS Phenytoin sodium Important anti-epilepsy medicine Pfizer fined £63 million Flynn fined 6.7 million NHS costs for rose from 2 million to 50 million in a single year CMA CEO: “These firms illegally exploited their dominant positions to charge the NHS excessive prices and make more money for themselves – meaning patients and taxpayers lost out” Fines are the result of an in-depth investigation Competition and Markets Authority Pfizer and Flynn charged unfairly high prices for capsules, for over 4 years, ultimately paid for by the NHS. Firms de-branded the drug, previously known as Epanutin, meaning it was no longer subject to price regulation and the firms could set prices at their discretion. Pfizer and Flynn were the dominant suppliers of the drug in the UK at the time, the NHS had no choice but to pay the inflated final price for this. Over the 4 years Pfizer charged prices between 780% and 1,600% higher than previously. The company supplied the drug to Flynn, which then sold the capsules on to wholesalers and pharmacies at a price between 2,300% and 2,600% higher than the prices previously charged by Pfizer. This illegal behaviour led to NHS annual costs for phenytoin capsules increasing from £2 million in 2012 to approximately £50 million the following year. Andrea Coscelli, Chief Executive CMA, Competition and Markets Authority Phenytoin is an essential drug relied on daily by thousands of people throughout the UK to prevent life-threatening epileptic seizures. These firms illegally exploited their dominant positions to charge the NHS excessive prices and make more money for themselves – meaning patients and taxpayers lost out. Such behaviour will not be tolerated, and the companies must now face the consequences of their illegal action. Pharma Companies Fined £70 Million for Overcharging the NHS https://www.medscape.co.uk/viewarticle/pharma-companies-fined-70-million-overcharging-nhs-2022a1001w5l?uac=127834AR&faf=1&sso=true&impID=4476264&src=mkm_ret_220801_mscpmrk_exclusiveuk_int https://www.gov.uk/government/organisations/competition-and-markets-authority https://www.gov.uk/government/news/cma-welcomes-court-of-appeal-judgment-in-phenytoin-case CMA welcomes Court of Appeal judgment in Phenytoin case BMJ https://www.bmj.com/content/355/bmj.i6628 Times https://www.thetimes.co.uk/article/pfizer-fined-63m-after-overcharging-nhs-for-phenytoin-sodium-epilepsy-drug-pqjphqbws Reuters https://www.reuters.com/business/healthcare-pharmaceuticals/uk-watchdog-fines-pharma-firms-pfizer-flynn-overcharging-nhs-2022-07-21/ Guardian https://www.theguardian.com/business/2022/jul/21/watchdog-fines-pfizer-and-flynn-70m-for-overcharging-nhs-for-epilepsy-drug FT https://www.ft.com/content/d2cd064d-55b2-484d-ab2c-d9a2f29bfc75 Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 6 · 25 min

    Natural resistance in Italy

    Clear graphics from Italy, The decline of COVID-19 severity and lethality over two years of pandemic https://www.medrxiv.org/content/10.1101/2022.07.01.22277137v1 20 to 40-fold reductions during the period of dominance of Omicron compared to the initial acute phase. Phase 1, Ancestral Probability of hospitalization per infection of 5.4% Probability of ICU admission of 0.65% Probability of death of 2.2% Phase 5, Omicron Probability of hospitalization, 95.1% reduction in risk Probability of ICU admission, 97.3% reduction in risk Probability of death, 97.5% reduction in risk Using epidemiological and genomic surveillance data To estimate the number of daily infections in Italy in the first two years of pandemic. Attack rate Ascertainment of SARS-CoV-2 infections Phase 1 (ancestral) NPIs Attack rate 2.8% Phase 2 (ancestral) Less stringent NPIs Attack rate 11.4% Phase 3 Alpha variant Mid -February 2021 to early July 2021 Alpha infected about 10.1% of the Italian population Phase 4, Delta Second half of 2021 Progressive relaxation of NPIs Attack rate 17.3% Phase 5, Omicron End of December 2021 Attack rate, 51.1% of the Italian population became infected with Omicron Evolution of population susceptibility Percentage of the population susceptible to SARS-CoV-2 End of first phase, 97.5% February 20, 2022, 13% By February 20th, 2022 a marked proportion of individuals unprotected against SARS-CoV-2 infection can be found among vaccinated subjects, due to the waning of vaccine protection Evolution of COVID-19 severity and lethality Probability of hospitalisation Probability of ICU admission Probability of death Evolution of population susceptibility Natural, post infection immunity is now the main factor reducing population sensitivity Vaccination protection is seen to be declining Omicron natural infection had the largest protective effect Repeat exposure to omicron (and sub variants) is likely to have the same effect going forward. NPIs will reduce repeat exposures NPIs will reduce exposure to other respiratory viruses such as RSV Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 6 · 37 min

    Deliberate destruction of biosamples

    With Professor of Medicine, Dr. Wendy Hoy and the aborted QoVax study. If we shed some light on events, perhaps a way forward might be devised. The Intent of this program was to study the effects and benefits of Covid Vaccines, through a prospective study over several years of a representative sample of adults in Queenland, which has one fifth of the Australia’s population and an area seven times that of the UK. Several of the major research and health care institutions in QLD were collaborators in the study. The Estimated cost over several years was to be Aus $20 million. It was a show-cased as a “real time study” with few to compare internationally. Participants gave detailed informed consent. Their vaccine status and Covid histories were recorded at baseline and ongoing (15% were unvaccinated at enrolment): and biosamples were gathered at baseline and ongoing. Biosamples included DNA, with the intern of evaluating potential genomic associations of susceptibility to Covid, as well as to reactions to and efficacy of the vaccines. In parallel, all hospital admissions, outcomes, deaths and costs, were to be followed through the existing linked data system built and maintained by Queensland Health, the state’s single public health service provider. Enrolment started in late July 2021: 10,600 participants were ultimately recruited: baseline observations and biosamples were acquired. Then longitudinal surveillance & intermittent biosampling began. It was suddenly announced in mid-2023, when many participants would have been followed for less than a year, that enrolment would cease, that the surveillance data would be indefinitely quarantined and the stored biosamples would be destroyed within 12 months. This occurred without advance notice or consultation of participants or of the study team. Explanations offered to the participants for this abrupt change in plan included competing needs for funding, and the claim that most of study questions had already been answered. However, questions about vaccine safety and efficacy have only ballooned over time, making this study a uniquely valuable resource of real time information to which there is little comparable, internationally. Perhaps Queensland Health was discouraged by early signals of vaccine harm in the program. The potential influence of pharma companies which have made major commitments to funding research in Queensland has been mentioned by Rebecca Weisser in the links provided. Over the following 12 months, the study team of 27 people was disbanded. Then, in May 2025, study participants were notified that the biosamples would be destroyed within the next 2 weeks, and the study data would be quarantined indefinitely. Protests about the action have included attempts to share this story more broadly : Sen Malcolm Roberts has made a powerful video presentation and several journalists have written powerful articles They also include actions to prevent destruction of samples and data. • On June 10, a petition was presented to Queenland parliament to halt the destruction of the samples and to protest cessation of the study. The Chief Petitioner was Mr Allen Ballard, with about 6,800 signatures • Mr Julian Gillespie, acting for legal firm, PJ O’Brien, has protested, on behalf of study participants, about destruction of the biosamples, arguing that it constitutes the criminal offence of destruction of evidence and of potential evidence. Notably, Mr Gillespie has for more than 2 years, been a global leader in promoting understanding and awareness of the DNA contamination of the mRNA vaccines, and its long term persistence in recipients. Queensland COVID-19 Vaccination Safety and Efficacy Statewide Study.//healthtranslationqld.org.au/news-events. 27 April 2022 Immediately halt the destruction of data, biospecimens, and preliminary reports as par Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 6 · 19 min

    Large European vaccine allocations

    And Doctors may be punished in California. 10 vaccine doses for every EU citizen MEP Mr. Cristian Terhes https://www.youtube.com/watch?v=beEfo7c_Weg&t=23s Ursula von der Leyen (President of the European commission) Her actions are currently criminally investigated Investigating the way the contract were signed Check on the European Public Prosecutor’s Office claim https://www.eppo.europa.eu/en Protecting European taxpayers’ money from criminals https://www.eppo.europa.eu/en/news/ongoing-eppo-investigation-acquisition-covid-19-vaccines-eu Court of auditors https://www.politico.eu/wp-content/uploads/2022/09/12/SR-19-2022-COVID-19-vaccine-procurement.pdf It (EU) took measures to help compress the development timeline for vaccines from 10-15 years to 12-24 months. November 2021 Commission had signed €71 billion worth of contracts to purchase up to 4.6 billion COVID-19 vaccine doses. EU population https://www.statista.com/statistics/253372/total-population-of-the-european-union-eu/ 2021, 447.01 million (more than 10 vaccines each) Contracts never released to the public The EU had to act ahead of clear scientific data on vaccine candidates’ safety and efficacy, and therefore chose to back a range of candidates The Pfizer/BioNTech vaccine dominates the portfolio in 2022-2023 because of, according to the Commission, the company’s ability to reliably supply the EU. California Approves Bill to Punish Doctors Who Spread False Information https://www.nytimes.com/2022/08/29/technology/california-doctors-covid-misinformation.html https://www.davisvanguard.org/2022/10/new-california-bill-attempts-to-prevent-doctors-from-spreading-covid-misinformation/ https://www.latimes.com/science/story/2022-10-06/spreading-lies-about-covid-19-could-get-doctors-disciplined-in-california California’s Legislature, Monday Doctors a duty to provide their patients with accurate, science-based information Approved bill allowing regulators to punish doctors, for spreading false information about Covid-19 vaccinations and treatments. Designate spreading false or misleading medical information, unprofessional conduct subject to punishment, Medical Board of California Holding incompetent or ill-intentioned doctors accountable State Senator Richard Pan In order for a patient to give informed consent, they have to be well informed Intended to address the most egregious cases of deliberately misleading patients. Governor Newsom, seems to be signed for 1st Jan 2023 American Medical Association Warned that spreading disinformation violates the code of ethics deliberately disseminated with malicious intent or an intent to mislead Spreading information that is contradicted by contemporary scientific consensus contrary to the standard of care Scope to deal directly with doctors’ direct interaction with patients (does not address comments online or on television) Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 6 · 23 min

    New treatment stopped

    Professor Angus Dalgleish, (Fellow of the Royal College of Physicians, Fellow of the Royal College of Pathologists, Fellow of Medical Science.) Professor Dalgleish is a highly experienced doctor, physician, medical teacher, medical author and researcher with over 500 primary research publications. He was also a pioneering researcher into HIV/AIDS. Here we discuss the recently observed changes in cancer presentations and deaths. Some of the discussion considers this research paper noting excess cancer deaths in Japan. Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan https://www.cureus.com/articles/196275-increased-age-adjusted-cancer-mortality-after-the-third-mrna-lipid-nanoparticle-vaccine-dose-during-the-covid-19-pandemic-in-japan#!/ Gibo M, Kojima S, Fujisawa A, et al. (April 08, 2024) Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan. Cureus 16(4): e57860. DOI 10.7759/cureus.57860 Conclusions Statistically significant increases in age-adjusted mortality rates of all cancer and some specific types of cancer, namely, ovarian cancer, leukemia, prostate, lip/oral/pharyngeal, pancreatic, and breast cancers, were observed in 2022 after two-thirds of the Japanese population had received the third or later dose of SARS-CoV-2 mRNA-LNP vaccine. These particularly marked increases in mortality rates of these ERα-sensitive cancers may be attributable to several mechanisms of the mRNA-LNP vaccination, rather than COVID-19 infection itself or reduced cancer care due to the lockdown. Researchers have reported that the SARS-CoV-2 mRNA-LNP vaccine may pose the risk of development and progression of cancer. Several case reports have described cancer developing or worsening after vaccination and discussed possible causal links between cancer and mRNA-LNP vaccination. Learn more about your ad choices. Visit megaphone.fm/adchoices

  • October 6 · 16 min

    Core T cells

    Professor Angus Dalgleish, (Fellow of the Royal College of Physicians, Fellow of the Royal College of Pathologists, Fellow of Medical Science.) Professor Dalgleish is a highly experienced doctor, physician, medical teacher, medical author and researcher with over 500 primary research publications. He was also a pioneering researcher into HIV/AIDS. Here we discuss the recently observed changes in cancer presentations and deaths. Some of the discussion considers this research paper noting excess cancer deaths in Japan. Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan https://www.cureus.com/articles/196275-increased-age-adjusted-cancer-mortality-after-the-third-mrna-lipid-nanoparticle-vaccine-dose-during-the-covid-19-pandemic-in-japan#!/ Gibo M, Kojima S, Fujisawa A, et al. (April 08, 2024) Increased Age-Adjusted Cancer Mortality After the Third mRNA-Lipid Nanoparticle Vaccine Dose During the COVID-19 Pandemic in Japan. Cureus 16(4): e57860. DOI 10.7759/cureus.57860 Conclusions Statistically significant increases in age-adjusted mortality rates of all cancer and some specific types of cancer, namely, ovarian cancer, leukemia, prostate, lip/oral/pharyngeal, pancreatic, and breast cancers, were observed in 2022 after two-thirds of the Japanese population had received the third or later dose of SARS-CoV-2 mRNA-LNP vaccine. These particularly marked increases in mortality rates of these ERα-sensitive cancers may be attributable to several mechanisms of the mRNA-LNP vaccination, rather than COVID-19 infection itself or reduced cancer care due to the lockdown. Researchers have reported that the SARS-CoV-2 mRNA-LNP vaccine may pose the risk of development and progression of cancer. Several case reports have described cancer developing or worsening after vaccination and discussed possible causal links between cancer and mRNA-LNP vaccination. Learn more about your ad choices. Visit megaphone.fm/adchoices

Showing 741–760 of 773 episodes